Usana Health Sciences USNA Income Statement (2010-2026)

NYSE USNA
$15.13 -0.07 (-0.49%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Usana Health Sciences Quarterly Income Statement

Periods 65 quarters
Latest Jul 2026

Usana Health Sciences reported revenue of $223.27M and net income of -$27.95M for the quarter ended Jul 2026, down 5.3% year over year. This income statement covers 65 quarters of results from Jul 2010 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Jan2026 Apr2026 Jul2026
Revenue & cost
Revenue
274.35M362.34M272.87M264.47M233.30M227.96M248.36M238.20M213.37M221.08M227.80M212.87M200.22M213.61M249.54M235.85M213.67M226.20M250.22M223.27M
Cost of RevenueCost of Rev
50.72M67.81M51.38M49.52M46.56M46.43M48.52M43.33M42.53M42.32M43.07M40.33M39.26M38.55M52.45M50.18M48.81M49.41M59.44M48.34M
Gross Profit
223.64M294.53M221.48M214.96M186.74M181.53M199.84M194.88M170.84M178.76M184.73M172.54M160.96M175.06M197.09M185.66M164.85M176.79M190.78M174.93M
Operating items
Selling, General & AdministrativeSG&A
66.64M87.09M68.80M66.39M66.02M61.10M66.93M68.10M63.30M58.66M64.30M64.33M61.30M73.35M91.44M81.91M85.95M78.08M88.25M82.32M
Other Operating ExpensesOther Opex
116.22M161.20M119.62M119.20M98.09M97.88M106.07M102.38M89.93M95.88M95.76M90.37M84.07M93.50M89.98M87.04M77.68M94.89M88.65M112.61M
Operating ExpensesOpex
182.87M248.29M188.42M185.59M164.11M158.98M173.00M170.48M153.23M154.54M160.06M154.70M145.36M166.85M181.42M168.95M163.63M172.97M176.91M194.93M
Operating IncomeOp. Inc
40.77M46.24M33.07M29.37M22.63M22.55M26.84M24.40M17.61M24.22M24.67M17.84M15.60M8.21M15.67M16.72M1.22M3.82M13.87M-20.00M
EBIT
40.77M46.24M33.07M29.37M22.63M22.55M26.84M24.40M17.61M24.22M24.67M17.84M15.60M8.21M15.67M16.72M1.22M3.82M13.87M-20.00M
Non-operating items
Non Operating Interest Expenses
0.02M-1.56M0.03M0.10M0.03M0.03M0.03M0.04M0.04M0.14M0.05M0.05M0.05M0.13M0.41M0.26M0.05M0.12M0.24M
Interest & Investment IncomeInt & Inv Inc
0.49M0.64M0.74M0.67M0.92M1.46M1.77M2.22M2.73M2.90M2.68M2.76M3.14M2.74M0.72M0.62M0.58M0.49M0.44M0.59M
Other Non Operating IncomeOther Non Op Inc.
-0.89M-3.19M0.55M-3.00M-1.13M0.99M-0.10M-0.52M0.23M0.41M-0.20M-0.35M0.84M-1.72M0.76M1.74M0.05M-0.01M1.39M0.61M
Non Operating IncomeNon Op. Inc.
-0.42M0.99M0.22M-0.06M0.59M0.25M1.66M2.41M2.92M2.39M2.44M2.36M3.01M2.22M1.07M2.10M0.57M0.36M1.59M1.10M
Net income details
EBT
40.35M47.23M33.29M29.31M23.22M22.80M28.50M26.81M20.53M26.61M27.11M20.20M18.61M10.43M16.74M18.82M1.79M4.18M15.46M-18.90M
Tax ProvisionsTaxes
13.02M15.76M10.82M10.15M8.29M10.01M10.12M9.52M9.18M9.85M10.57M9.77M8.00M5.95M7.45M8.37M8.46M5.77M8.51M9.05M
Profit After TaxPAT
27.33M34.73M22.47M19.16M14.93M12.79M20.14M17.29M11.35M16.77M16.54M10.43M17.42M4.48M9.40M13.85M-6.66M1.52M9.26M-27.95M
Income from Non-Controlling InterestsInc. Minority
0.03M-0.11M0.79M-0.14M0.18M-0.56M-6.57M
Income from Continuing OperationsIncome (Continuing)
27.33M31.47M22.47M19.16M14.93M12.79M18.38M17.29M11.35M16.77M16.54M10.43M10.61M4.48M9.29M10.44M-6.66M-1.59M6.96M-27.95M
Consolidated Net IncomeConsol Net Inc.
27.33M31.47M22.47M19.16M14.93M12.79M18.38M17.29M11.35M16.77M16.54M10.43M10.61M4.48M9.29M10.44M-6.66M-1.59M6.96M-27.95M
Income towards Parent CompanyParent Net Inc
27.33M31.47M22.47M19.16M14.93M12.79M18.38M17.29M11.35M16.77M16.54M10.43M10.61M4.48M9.29M10.44M-6.66M-1.59M6.96M-27.95M
Net Income towards Common StockholdersNet Income
27.33M20.32M22.47M19.16M14.93M12.79M18.38M17.29M11.35M16.77M16.54M10.43M10.61M4.48M9.29M10.44M-6.66M-1.59M6.96M-27.95M
Additional items
EPS (Basic)
1.371.011.161.000.780.660.950.890.590.870.860.550.560.230.490.56-0.36-0.090.38-1.51
EPS (Diluted)
1.361.001.151.000.780.660.950.890.590.870.860.540.560.230.490.56-0.36-0.090.38-1.51
Shares Outstanding
19.96M20.15M19.35M19.21M19.22M19.25M19.28M19.32M19.25M19.25M19.17M19.07M19.08M19.10M19.05M18.51M18.29M18.54M18.40M18.49M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
20.16M20.34M19.48M19.24M19.25M19.31M19.33M19.43M19.37M19.34M19.30M19.16M19.08M19.16M19.09M18.54M18.29M18.57M18.41M18.49M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
19.65M19.39M19.18M19.20M19.20M19.21M19.29M19.30M19.12M19.13M19.05M19.05M19.06M19.06M18.79M18.26M18.27M18.28M18.46M18.46M
EBITDA
40.77M46.24M33.07M29.37M22.63M22.55M26.84M24.40M17.61M24.22M24.67M17.84M15.60M8.21M15.67M16.72M1.22M3.82M13.87M-20.00M
Interest ExpensesInt Expense
0.02M-1.56M0.03M0.10M0.03M0.03M0.03M0.04M0.04M0.14M0.05M0.05M0.05M0.13M0.41M0.26M0.05M0.12M0.24M
Tax Rate
32.27%33.36%32.50%34.64%35.72%43.89%35.50%35.50%44.73%37.00%39.00%48.36%43.00%57.00%44.50%44.50%471.35%138.19%55.00%-47.89%